Building on this groundwork, Yao et al. explored how TGF-β1 drives fibroblast-to-myofibroblast differentiation in ovarian cancer, linking this transformation to an upregulated ROS-CLIC4 pathway. Here, TGFB1 is linked to ovarian carcinoma.